- Rosiglitazone antagonizes vascular endothelial growth factor signaling and nuclear factor of activated T cells activation in cardiac valve endothelium. Sander, T.L., Noll, L., Klinkner, D.B., Weihrauch, D., He, B.J., Kaul, S., Zangwill, S.D., Tweddell, J.S., Pritchard, K.A., Oldham, K.T. Endothelium (2006)